abduraimov-y 1
1. Phylogenetic analysis of prospective M. bovis antigens with the aim of developing candidate vaccines for bovine tuberculosis
2. Safety and Protective Efficacy of a Candidate Vector-Based Vaccine for Bovine Tuberculosis
3. Serological surveillance of Trypanosoma evansi in Kazakhstani camels by complement fixation and formalin gel tests
4. Duration of protective immunity in sheep vaccinated with a combined vaccine against peste des petits ruminants and sheep pox
5. Development of a Bacterial Lysate from Antibiotic-Resistant Pathogens Causing Hospital Infections
6. Phylogenetic analysis of a 2024 Sheeppox virus isolate from the Almaty region of Kazakhstan and investigation of its pathogenicity in merino sheep
7. Bovine Viral Diarrhea in Kazakhstan
8. Epidemiology, Virology, and Control of Highly Pathogenic Avian Influenza in Kazakhstan
9. Tuberculosis and Impact of COVID-19 on Spread of Epidemics in Kazakhstan
10. Duration of immunity against infectious rhinotracheitis and bovine viral diarrhea after vaccination in calves in southern region of Kazakhstan
11. The Influence of the Associated Inactivated Vaccine Against Infectious Rhinotracheitis and Bovine Viral Diarrhea on the Formation and Duration of Colostral Immunity in Kazakh Whiteheaded Calves
12. Coding Complete Genome Sequence of the SARS-CoV-2 Virus Strain, Variant B.1.1, Sampled from Kazakhstan
13. Complete Coding Genome Sequence of an Influenza A/H3N8 Equine Virus Isolated in Kazakhstan in 2007
14. Preclinical safety and burn wound healing activity of “Novostron”, a novel topical iodine-based therapeutic
15. Safety Assessment: a Comparative Analysis of Quantitative Content of Bacterial Endotoxins and Evaluation of Pyrogenicity of the Kazakhstan Vaccine QazCovid-in® against COVID-19
16. Serological and molecular surveillance of infectious bovine rhinotracheitis in Kazakhstan
17. Development and validation of a regionally adapted sandwich enzyme-linked immunosorbent assay targeting recombinant p60 antigen for rapid detection of Listeria monocytogenes in food samples
18. Efficacy and safety of an inactivated whole-virion vaccine against COVID-19, QazCovid-in®, in healthy adults: A multicentre, randomised, single-blind, placebo-controlled phase 3 clinical trial with a 6-month follow-up
19. Synthetic genomics-based generation of the tick-borne encephalitis virus Siberian subtype prototype strain and E51K-attenuated variant for vaccine development and antiviral screening
20. Improved Efficiency of Bluetongue Viral Antigen Isolation for Successful Immunization
21. Investigation of the Pathogenesis of Lumpy Skin Disease Virus in Indigenous Cattle in Kazakhstan
22. Determination of the minimal level of neutralizing antibodies elicited following vaccination able to protect rabbits against virulent cowpox virus
23. Development and validation of a recombinant Rap1-based lateral flow immunoassay for rapid serodiagnosis of bovine babesiosis in Kazakhstan
24. First report on identification of Salmonella Abortusovis from ovine abortion cases in Kazakhstan
25. Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
26. Development and Application of a Quantitative Polymerase Chain Reaction Assay for the Detection and Genotyping of Bovine Leukemia Virus in Cattle From Kazakhstan
27. Isolation and study of a strain of lumpy skin disease virus of cattle
28. Pre-Clinical Safety and Immunogenicity Study of a Coronavirus Protein-Based Subunit Vaccine for COVID-19
29. Complete Coding Sequence of a Lineage AY.122 SARS-CoV-2 Virus Strain Detected in Kazakhstan
30. Near-Complete Genome Sequence of a SARS-CoV-2 Variant B.1.1.7 Virus Strain Isolated in Kazakhstan
31. Safety and immunogenicity of a QazCovid-in® inactivated whole-virion vaccine against COVID-19 in healthy adults: A single-centre, randomised, single-blind, placebo-controlled phase 1 and an open-label phase 2 clinical trials with a 6 months follow-up in Kazakhstan
32. Development and Evaluation of a Live Attenuated Egg-Based Camelpox Vaccine
33. Development of an Inactivated Camelpox Vaccine from Attenuated Camelpox Virus Strain: Safety and Protection in Camels
34. Development of the Inactivated QazCovid-in Vaccine: Protective Efficacy of the Vaccine in Syrian Hamsters
1